Medical Care
Global Sickle Cell Treatment Market Research Report 2025
- Apr 07, 25
- ID: 167445
- Pages: 86
- Figures: 81
- Views: 42
The global market for Sickle Cell Treatment was valued at US$ 242 million in the year 2024 and is projected to reach a revised size of US$ 352 million by 2031, growing at a CAGR of 5.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Treatment.
The Sickle Cell Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sickle Cell Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Global Blood Therapeutics Inc.
EMI Holding, Inc.
Addmedica Inc.
Medunik USA.Inc.
Bristol Myers Squibb Co.
Baxter Inc.
Bluebird Biotechnology
Pfizer Inc.
Eli-Lilly and Co.
Glycomimetics Inc.
F.Hoffmann-La Roche
CRISPR Therapeutics
Segment by Type
Blood Transfusion
Bone Marrow Transplant
Pharmacotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sickle Cell Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Treatment.
The Sickle Cell Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sickle Cell Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sickle Cell Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Global Blood Therapeutics Inc.
EMI Holding, Inc.
Addmedica Inc.
Medunik USA.Inc.
Bristol Myers Squibb Co.
Baxter Inc.
Bluebird Biotechnology
Pfizer Inc.
Eli-Lilly and Co.
Glycomimetics Inc.
F.Hoffmann-La Roche
CRISPR Therapeutics
Segment by Type
Blood Transfusion
Bone Marrow Transplant
Pharmacotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Transfusion
1.2.3 Bone Marrow Transplant
1.2.4 Pharmacotherapy
1.3 Market by Application
1.3.1 Global Sickle Cell Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Treatment Market Perspective (2020-2031)
2.2 Global Sickle Cell Treatment Growth Trends by Region
2.2.1 Global Sickle Cell Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sickle Cell Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sickle Cell Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sickle Cell Treatment Market Dynamics
2.3.1 Sickle Cell Treatment Industry Trends
2.3.2 Sickle Cell Treatment Market Drivers
2.3.3 Sickle Cell Treatment Market Challenges
2.3.4 Sickle Cell Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Treatment Players by Revenue (2020-2025)
3.1.2 Global Sickle Cell Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sickle Cell Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sickle Cell Treatment Revenue
3.4 Global Sickle Cell Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Treatment Revenue in 2024
3.5 Global Key Players of Sickle Cell Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Treatment Breakdown Data by Type
4.1 Global Sickle Cell Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031)
5 Sickle Cell Treatment Breakdown Data by Application
5.1 Global Sickle Cell Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sickle Cell Treatment Market Size (2020-2031)
6.2 North America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sickle Cell Treatment Market Size by Country (2020-2025)
6.4 North America Sickle Cell Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Treatment Market Size (2020-2031)
7.2 Europe Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sickle Cell Treatment Market Size by Country (2020-2025)
7.4 Europe Sickle Cell Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sickle Cell Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Treatment Market Size (2020-2031)
9.2 Latin America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sickle Cell Treatment Market Size by Country (2020-2025)
9.4 Latin America Sickle Cell Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Sickle Cell Treatment Introduction
11.1.4 Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Global Blood Therapeutics Inc.
11.2.1 Global Blood Therapeutics Inc. Company Details
11.2.2 Global Blood Therapeutics Inc. Business Overview
11.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Introduction
11.2.4 Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.2.5 Global Blood Therapeutics Inc. Recent Development
11.3 EMI Holding, Inc.
11.3.1 EMI Holding, Inc. Company Details
11.3.2 EMI Holding, Inc. Business Overview
11.3.3 EMI Holding, Inc. Sickle Cell Treatment Introduction
11.3.4 EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.3.5 EMI Holding, Inc. Recent Development
11.4 Addmedica Inc.
11.4.1 Addmedica Inc. Company Details
11.4.2 Addmedica Inc. Business Overview
11.4.3 Addmedica Inc. Sickle Cell Treatment Introduction
11.4.4 Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.4.5 Addmedica Inc. Recent Development
11.5 Medunik USA.Inc.
11.5.1 Medunik USA.Inc. Company Details
11.5.2 Medunik USA.Inc. Business Overview
11.5.3 Medunik USA.Inc. Sickle Cell Treatment Introduction
11.5.4 Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.5.5 Medunik USA.Inc. Recent Development
11.6 Bristol Myers Squibb Co.
11.6.1 Bristol Myers Squibb Co. Company Details
11.6.2 Bristol Myers Squibb Co. Business Overview
11.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Introduction
11.6.4 Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025)
11.6.5 Bristol Myers Squibb Co. Recent Development
11.7 Baxter Inc.
11.7.1 Baxter Inc. Company Details
11.7.2 Baxter Inc. Business Overview
11.7.3 Baxter Inc. Sickle Cell Treatment Introduction
11.7.4 Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.7.5 Baxter Inc. Recent Development
11.8 Bluebird Biotechnology
11.8.1 Bluebird Biotechnology Company Details
11.8.2 Bluebird Biotechnology Business Overview
11.8.3 Bluebird Biotechnology Sickle Cell Treatment Introduction
11.8.4 Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025)
11.8.5 Bluebird Biotechnology Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Sickle Cell Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 Eli-Lilly and Co.
11.10.1 Eli-Lilly and Co. Company Details
11.10.2 Eli-Lilly and Co. Business Overview
11.10.3 Eli-Lilly and Co. Sickle Cell Treatment Introduction
11.10.4 Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025)
11.10.5 Eli-Lilly and Co. Recent Development
11.11 Glycomimetics Inc.
11.11.1 Glycomimetics Inc. Company Details
11.11.2 Glycomimetics Inc. Business Overview
11.11.3 Glycomimetics Inc. Sickle Cell Treatment Introduction
11.11.4 Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.11.5 Glycomimetics Inc. Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 CRISPR Therapeutics
11.13.1 CRISPR Therapeutics Company Details
11.13.2 CRISPR Therapeutics Business Overview
11.13.3 CRISPR Therapeutics Sickle Cell Treatment Introduction
11.13.4 CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025)
11.13.5 CRISPR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Transfusion
1.2.3 Bone Marrow Transplant
1.2.4 Pharmacotherapy
1.3 Market by Application
1.3.1 Global Sickle Cell Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Treatment Market Perspective (2020-2031)
2.2 Global Sickle Cell Treatment Growth Trends by Region
2.2.1 Global Sickle Cell Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sickle Cell Treatment Historic Market Size by Region (2020-2025)
2.2.3 Sickle Cell Treatment Forecasted Market Size by Region (2026-2031)
2.3 Sickle Cell Treatment Market Dynamics
2.3.1 Sickle Cell Treatment Industry Trends
2.3.2 Sickle Cell Treatment Market Drivers
2.3.3 Sickle Cell Treatment Market Challenges
2.3.4 Sickle Cell Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Treatment Players by Revenue (2020-2025)
3.1.2 Global Sickle Cell Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Sickle Cell Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sickle Cell Treatment Revenue
3.4 Global Sickle Cell Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Treatment Revenue in 2024
3.5 Global Key Players of Sickle Cell Treatment Head office and Area Served
3.6 Global Key Players of Sickle Cell Treatment, Product and Application
3.7 Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Treatment Breakdown Data by Type
4.1 Global Sickle Cell Treatment Historic Market Size by Type (2020-2025)
4.2 Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031)
5 Sickle Cell Treatment Breakdown Data by Application
5.1 Global Sickle Cell Treatment Historic Market Size by Application (2020-2025)
5.2 Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sickle Cell Treatment Market Size (2020-2031)
6.2 North America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sickle Cell Treatment Market Size by Country (2020-2025)
6.4 North America Sickle Cell Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle Cell Treatment Market Size (2020-2031)
7.2 Europe Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sickle Cell Treatment Market Size by Country (2020-2025)
7.4 Europe Sickle Cell Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Treatment Market Size (2020-2031)
8.2 Asia-Pacific Sickle Cell Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle Cell Treatment Market Size (2020-2031)
9.2 Latin America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sickle Cell Treatment Market Size by Country (2020-2025)
9.4 Latin America Sickle Cell Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Treatment Market Size (2020-2031)
10.2 Middle East & Africa Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Sickle Cell Treatment Introduction
11.1.4 Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Global Blood Therapeutics Inc.
11.2.1 Global Blood Therapeutics Inc. Company Details
11.2.2 Global Blood Therapeutics Inc. Business Overview
11.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Introduction
11.2.4 Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.2.5 Global Blood Therapeutics Inc. Recent Development
11.3 EMI Holding, Inc.
11.3.1 EMI Holding, Inc. Company Details
11.3.2 EMI Holding, Inc. Business Overview
11.3.3 EMI Holding, Inc. Sickle Cell Treatment Introduction
11.3.4 EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.3.5 EMI Holding, Inc. Recent Development
11.4 Addmedica Inc.
11.4.1 Addmedica Inc. Company Details
11.4.2 Addmedica Inc. Business Overview
11.4.3 Addmedica Inc. Sickle Cell Treatment Introduction
11.4.4 Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.4.5 Addmedica Inc. Recent Development
11.5 Medunik USA.Inc.
11.5.1 Medunik USA.Inc. Company Details
11.5.2 Medunik USA.Inc. Business Overview
11.5.3 Medunik USA.Inc. Sickle Cell Treatment Introduction
11.5.4 Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.5.5 Medunik USA.Inc. Recent Development
11.6 Bristol Myers Squibb Co.
11.6.1 Bristol Myers Squibb Co. Company Details
11.6.2 Bristol Myers Squibb Co. Business Overview
11.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Introduction
11.6.4 Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025)
11.6.5 Bristol Myers Squibb Co. Recent Development
11.7 Baxter Inc.
11.7.1 Baxter Inc. Company Details
11.7.2 Baxter Inc. Business Overview
11.7.3 Baxter Inc. Sickle Cell Treatment Introduction
11.7.4 Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.7.5 Baxter Inc. Recent Development
11.8 Bluebird Biotechnology
11.8.1 Bluebird Biotechnology Company Details
11.8.2 Bluebird Biotechnology Business Overview
11.8.3 Bluebird Biotechnology Sickle Cell Treatment Introduction
11.8.4 Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025)
11.8.5 Bluebird Biotechnology Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Sickle Cell Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 Eli-Lilly and Co.
11.10.1 Eli-Lilly and Co. Company Details
11.10.2 Eli-Lilly and Co. Business Overview
11.10.3 Eli-Lilly and Co. Sickle Cell Treatment Introduction
11.10.4 Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025)
11.10.5 Eli-Lilly and Co. Recent Development
11.11 Glycomimetics Inc.
11.11.1 Glycomimetics Inc. Company Details
11.11.2 Glycomimetics Inc. Business Overview
11.11.3 Glycomimetics Inc. Sickle Cell Treatment Introduction
11.11.4 Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)
11.11.5 Glycomimetics Inc. Recent Development
11.12 F.Hoffmann-La Roche
11.12.1 F.Hoffmann-La Roche Company Details
11.12.2 F.Hoffmann-La Roche Business Overview
11.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Introduction
11.12.4 F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025)
11.12.5 F.Hoffmann-La Roche Recent Development
11.13 CRISPR Therapeutics
11.13.1 CRISPR Therapeutics Company Details
11.13.2 CRISPR Therapeutics Business Overview
11.13.3 CRISPR Therapeutics Sickle Cell Treatment Introduction
11.13.4 CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025)
11.13.5 CRISPR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sickle Cell Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Bone Marrow Transplant
Table 4. Key Players of Pharmacotherapy
Table 5. Global Sickle Cell Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sickle Cell Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sickle Cell Treatment Market Share by Region (2020-2025)
Table 9. Global Sickle Cell Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sickle Cell Treatment Market Share by Region (2026-2031)
Table 11. Sickle Cell Treatment Market Trends
Table 12. Sickle Cell Treatment Market Drivers
Table 13. Sickle Cell Treatment Market Challenges
Table 14. Sickle Cell Treatment Market Restraints
Table 15. Global Sickle Cell Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sickle Cell Treatment Market Share by Players (2020-2025)
Table 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)
Table 18. Ranking of Global Top Sickle Cell Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sickle Cell Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sickle Cell Treatment, Headquarters and Area Served
Table 21. Global Key Players of Sickle Cell Treatment, Product and Application
Table 22. Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sickle Cell Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sickle Cell Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Sickle Cell Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sickle Cell Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sickle Cell Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sickle Cell Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Sickle Cell Treatment Product
Table 50. Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Global Blood Therapeutics Inc. Company Details
Table 53. Global Blood Therapeutics Inc. Business Overview
Table 54. Global Blood Therapeutics Inc. Sickle Cell Treatment Product
Table 55. Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 56. Global Blood Therapeutics Inc. Recent Development
Table 57. EMI Holding, Inc. Company Details
Table 58. EMI Holding, Inc. Business Overview
Table 59. EMI Holding, Inc. Sickle Cell Treatment Product
Table 60. EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 61. EMI Holding, Inc. Recent Development
Table 62. Addmedica Inc. Company Details
Table 63. Addmedica Inc. Business Overview
Table 64. Addmedica Inc. Sickle Cell Treatment Product
Table 65. Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 66. Addmedica Inc. Recent Development
Table 67. Medunik USA.Inc. Company Details
Table 68. Medunik USA.Inc. Business Overview
Table 69. Medunik USA.Inc. Sickle Cell Treatment Product
Table 70. Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 71. Medunik USA.Inc. Recent Development
Table 72. Bristol Myers Squibb Co. Company Details
Table 73. Bristol Myers Squibb Co. Business Overview
Table 74. Bristol Myers Squibb Co. Sickle Cell Treatment Product
Table 75. Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 76. Bristol Myers Squibb Co. Recent Development
Table 77. Baxter Inc. Company Details
Table 78. Baxter Inc. Business Overview
Table 79. Baxter Inc. Sickle Cell Treatment Product
Table 80. Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 81. Baxter Inc. Recent Development
Table 82. Bluebird Biotechnology Company Details
Table 83. Bluebird Biotechnology Business Overview
Table 84. Bluebird Biotechnology Sickle Cell Treatment Product
Table 85. Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 86. Bluebird Biotechnology Recent Development
Table 87. Pfizer Inc. Company Details
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. Sickle Cell Treatment Product
Table 90. Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. Eli-Lilly and Co. Company Details
Table 93. Eli-Lilly and Co. Business Overview
Table 94. Eli-Lilly and Co. Sickle Cell Treatment Product
Table 95. Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 96. Eli-Lilly and Co. Recent Development
Table 97. Glycomimetics Inc. Company Details
Table 98. Glycomimetics Inc. Business Overview
Table 99. Glycomimetics Inc. Sickle Cell Treatment Product
Table 100. Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 101. Glycomimetics Inc. Recent Development
Table 102. F.Hoffmann-La Roche Company Details
Table 103. F.Hoffmann-La Roche Business Overview
Table 104. F.Hoffmann-La Roche Sickle Cell Treatment Product
Table 105. F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 106. F.Hoffmann-La Roche Recent Development
Table 107. CRISPR Therapeutics Company Details
Table 108. CRISPR Therapeutics Business Overview
Table 109. CRISPR Therapeutics Sickle Cell Treatment Product
Table 110. CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 111. CRISPR Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Sickle Cell Treatment Picture
Figure 2. Global Sickle Cell Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sickle Cell Treatment Market Share by Type: 2024 VS 2031
Figure 4. Blood Transfusion Features
Figure 5. Bone Marrow Transplant Features
Figure 6. Pharmacotherapy Features
Figure 7. Global Sickle Cell Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sickle Cell Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Sickle Cell Treatment Report Years Considered
Figure 13. Global Sickle Cell Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Sickle Cell Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sickle Cell Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Sickle Cell Treatment Market Share by Players in 2024
Figure 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2024
Figure 19. North America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 21. United States Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 25. Germany Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sickle Cell Treatment Market Share by Region (2020-2031)
Figure 33. China Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 49. Global Blood Therapeutics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 50. EMI Holding, Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 51. Addmedica Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 52. Medunik USA.Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 53. Bristol Myers Squibb Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 54. Baxter Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 55. Bluebird Biotechnology Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 56. Pfizer Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 57. Eli-Lilly and Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 58. Glycomimetics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 59. F.Hoffmann-La Roche Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 60. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Sickle Cell Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Bone Marrow Transplant
Table 4. Key Players of Pharmacotherapy
Table 5. Global Sickle Cell Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sickle Cell Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sickle Cell Treatment Market Share by Region (2020-2025)
Table 9. Global Sickle Cell Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sickle Cell Treatment Market Share by Region (2026-2031)
Table 11. Sickle Cell Treatment Market Trends
Table 12. Sickle Cell Treatment Market Drivers
Table 13. Sickle Cell Treatment Market Challenges
Table 14. Sickle Cell Treatment Market Restraints
Table 15. Global Sickle Cell Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sickle Cell Treatment Market Share by Players (2020-2025)
Table 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)
Table 18. Ranking of Global Top Sickle Cell Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sickle Cell Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sickle Cell Treatment, Headquarters and Area Served
Table 21. Global Key Players of Sickle Cell Treatment, Product and Application
Table 22. Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle Cell Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sickle Cell Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sickle Cell Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Sickle Cell Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sickle Cell Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sickle Cell Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sickle Cell Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Sickle Cell Treatment Product
Table 50. Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Global Blood Therapeutics Inc. Company Details
Table 53. Global Blood Therapeutics Inc. Business Overview
Table 54. Global Blood Therapeutics Inc. Sickle Cell Treatment Product
Table 55. Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 56. Global Blood Therapeutics Inc. Recent Development
Table 57. EMI Holding, Inc. Company Details
Table 58. EMI Holding, Inc. Business Overview
Table 59. EMI Holding, Inc. Sickle Cell Treatment Product
Table 60. EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 61. EMI Holding, Inc. Recent Development
Table 62. Addmedica Inc. Company Details
Table 63. Addmedica Inc. Business Overview
Table 64. Addmedica Inc. Sickle Cell Treatment Product
Table 65. Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 66. Addmedica Inc. Recent Development
Table 67. Medunik USA.Inc. Company Details
Table 68. Medunik USA.Inc. Business Overview
Table 69. Medunik USA.Inc. Sickle Cell Treatment Product
Table 70. Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 71. Medunik USA.Inc. Recent Development
Table 72. Bristol Myers Squibb Co. Company Details
Table 73. Bristol Myers Squibb Co. Business Overview
Table 74. Bristol Myers Squibb Co. Sickle Cell Treatment Product
Table 75. Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 76. Bristol Myers Squibb Co. Recent Development
Table 77. Baxter Inc. Company Details
Table 78. Baxter Inc. Business Overview
Table 79. Baxter Inc. Sickle Cell Treatment Product
Table 80. Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 81. Baxter Inc. Recent Development
Table 82. Bluebird Biotechnology Company Details
Table 83. Bluebird Biotechnology Business Overview
Table 84. Bluebird Biotechnology Sickle Cell Treatment Product
Table 85. Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 86. Bluebird Biotechnology Recent Development
Table 87. Pfizer Inc. Company Details
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. Sickle Cell Treatment Product
Table 90. Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. Eli-Lilly and Co. Company Details
Table 93. Eli-Lilly and Co. Business Overview
Table 94. Eli-Lilly and Co. Sickle Cell Treatment Product
Table 95. Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 96. Eli-Lilly and Co. Recent Development
Table 97. Glycomimetics Inc. Company Details
Table 98. Glycomimetics Inc. Business Overview
Table 99. Glycomimetics Inc. Sickle Cell Treatment Product
Table 100. Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 101. Glycomimetics Inc. Recent Development
Table 102. F.Hoffmann-La Roche Company Details
Table 103. F.Hoffmann-La Roche Business Overview
Table 104. F.Hoffmann-La Roche Sickle Cell Treatment Product
Table 105. F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 106. F.Hoffmann-La Roche Recent Development
Table 107. CRISPR Therapeutics Company Details
Table 108. CRISPR Therapeutics Business Overview
Table 109. CRISPR Therapeutics Sickle Cell Treatment Product
Table 110. CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)
Table 111. CRISPR Therapeutics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Sickle Cell Treatment Picture
Figure 2. Global Sickle Cell Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sickle Cell Treatment Market Share by Type: 2024 VS 2031
Figure 4. Blood Transfusion Features
Figure 5. Bone Marrow Transplant Features
Figure 6. Pharmacotherapy Features
Figure 7. Global Sickle Cell Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sickle Cell Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Sickle Cell Treatment Report Years Considered
Figure 13. Global Sickle Cell Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Sickle Cell Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Sickle Cell Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Sickle Cell Treatment Market Share by Players in 2024
Figure 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2024
Figure 19. North America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 21. United States Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 25. Germany Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sickle Cell Treatment Market Share by Region (2020-2031)
Figure 33. China Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sickle Cell Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 49. Global Blood Therapeutics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 50. EMI Holding, Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 51. Addmedica Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 52. Medunik USA.Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 53. Bristol Myers Squibb Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 54. Baxter Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 55. Bluebird Biotechnology Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 56. Pfizer Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 57. Eli-Lilly and Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 58. Glycomimetics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 59. F.Hoffmann-La Roche Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 60. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232